Life Sciences Market Research Report

Report Filter Reset All

Sort By Price

Published Date

Category

Clear All

Publishers

Clear All

Report Type

Continents

Clear All

Regions

Clear All

Countries

Clear All

Pharma & Healthcare

Global Iclusig Market Insights, Forecast to 2025

Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acut...

$3,900.00 14 June, 2019 | QYResearch

Global Iclusig Market Insights, Forecast to 2025

$3,900.00 | 14 June, 2019 | QYResearch

Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive ...

Pharma & Healthcare

Global Vincristine Sulfate Liposome Injection Market Insights, Forecast to 2025

Marqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration. The globa...

$3,900.00 14 June, 2019 | QYResearch

Marqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration....

Pharma & Healthcare

Global Xatmep Market Insights, Forecast to 2025

Xatmep is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortion...

$3,900.00 14 June, 2019 | QYResearch

Global Xatmep Market Insights, Forecast to 2025

$3,900.00 | 14 June, 2019 | QYResearch

Xatmep is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medica...

Pharma & Healthcare

Global Bone Metastasis Market Insights, Forecast to 2025

Bone metastases, or osseous metastatic disease, is a category of cancer metastases that results from primary tumor invasion to bone. Bone-originating primary...

$3,900.00 14 June, 2019 | QYResearch

Global Bone Metastasis Market Insights, Forecast to 2025

$3,900.00 | 14 June, 2019 | QYResearch

Bone metastases, or osseous metastatic disease, is a category of cancer metastases that results from primary tumor invasion to bone. Bone-originati...

Pharma & Healthcare

Global Sophocarpidine (CAS:519-02-8) Market Insights, Forecast to 2025

Sophocarpidine is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely u...

$3,900.00 14 June, 2019 | QYResearch

Sophocarpidine is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine an...

Pharma & Healthcare

Global Prothrombin Complex Concentrates Market Insights, Forecast to 2025

Prothrombin concentrates also known as prothrombin complex concentrates (PCC) are medications containing various clotting factors. PCCs are used for treating...

$3,900.00 14 June, 2019 | QYResearch

Prothrombin concentrates also known as prothrombin complex concentrates (PCC) are medications containing various clotting factors. PCCs are used fo...

Pharma & Healthcare

Cocokara Fine Inc - Strategy, SWOT and Corporate Finance Report

Cocokara Fine Inc - Strategy, SWOT and Corporate Finance Report Summary Cocokara Fine Inc - Strategy, SWOT and Corporate Finance Report, is a source of com...

$175.00 14 June, 2019 | MarketLine

Cocokara Fine Inc - Strategy, SWOT and Corporate Finance Report Summary Cocokara Fine Inc - Strategy, SWOT and Corporate Finance Report, is a sou...

Pharma & Healthcare

CRISPR Therapeutics AG - Strategy, SWOT and Corporate Finance Report

CRISPR Therapeutics AG - Strategy, SWOT and Corporate Finance Report Summary CRISPR Therapeutics AG - Strategy, SWOT and Corporate Finance Report, is a sou...

$175.00 14 June, 2019 | MarketLine

CRISPR Therapeutics AG - Strategy, SWOT and Corporate Finance Report Summary CRISPR Therapeutics AG - Strategy, SWOT and Corporate Finance Report...

Pharma & Healthcare

Syneos Health Inc - Strategy, SWOT and Corporate Finance Report

Syneos Health Inc - Strategy, SWOT and Corporate Finance Report Summary Syneos Health Inc - Strategy, SWOT and Corporate Finance Report, is a source of com...

$175.00 14 June, 2019 | MarketLine

Syneos Health Inc - Strategy, SWOT and Corporate Finance Report Summary Syneos Health Inc - Strategy, SWOT and Corporate Finance Report, is a sou...

Pharma & Healthcare

AS ONE Corp - Strategy, SWOT and Corporate Finance Report

AS ONE Corp - Strategy, SWOT and Corporate Finance Report Summary AS ONE Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive c...

$175.00 14 June, 2019 | MarketLine

AS ONE Corp - Strategy, SWOT and Corporate Finance Report Summary AS ONE Corp - Strategy, SWOT and Corporate Finance Report, is a source of compr...